ADC Pharmacokinetics and Clinical Pharmacology Summit
Evvnt Promotion / evvnt
Archivio
08.10.2024 - 10.10.2024 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 8:00 am to 5:00 pm
Temi della conferenza
Antibody-drug conjugates (ADCs) have emerged as a rapidly evolving, highly promising class of oncology drugs, with 12 approvals and many more in development. Despite their success, the therapeutic window remains relatively narrow, posing challenges for finding an optimal dose.
Antibody-drug conjugates (ADCs) have emerged as a rapidly evolving, highly promising class of oncology drugs, with 12 approvals and many more in development. Despite their success, the therapeutic window remains relatively narrow, posing challenges for finding an optimal dose.
Scientific organizer
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/2465910-3?pid=4832
Speakers: Alison Betts, Global Head of DMPK and Modeling, Takeda, Andras Strassz, Chief Medical Officer, Heidelberg Pharma Research GmbH and more
Brochure: https://go.evvnt.com/2465910-3?pid=4832
Speakers: Alison Betts, Global Head of DMPK and Modeling, Takeda, Andras Strassz, Chief Medical Officer, Heidelberg Pharma Research GmbH and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2465910-1?pid=4832
Ms. Abigail Cox
Servizi sanitari
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
